Bortezomib-Dexamethasone-Doxorubicin-Study

Update Il y a 4 ans
Reference: NCT00401804

Woman and Man

Extract

The primary objective of the study is to evaluate the activity of BDD in subjects with acute renal failure as measured by· reversal of acute renal failureSecondary objectives· tumor response (complete and partial response)· To evaluate the safety of Bortezomib- Doxorubicin-Dexamethasone in this patient population· to evaluate the activity of Bortezomib- Doxorubicin -Dexamethasone on progression free survival · to evaluate the activity of Bortezomib- Doxorubicin -Dexamethasone on overall survival


Inclusion criteria

  • Multiple myeloma ,Renal Insuficiency

Links